Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors
Clinical trial NCT04859569 · UNKNOWN
Trial details
- NCT number
- NCT04859569
- Sponsor
- Luye Pharma Group Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2022-12-31
- Enrollment
- 850
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.